Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm

Oncology (Williston Park). 2016 Feb;30(2):160-2, 176.
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma / drug therapy*
  • Carcinoma / enzymology
  • Carcinoma / immunology
  • Carcinoma / mortality
  • Carcinoma / pathology
  • Cell Cycle Checkpoints / drug effects*
  • Cell Cycle Proteins / antagonists & inhibitors*
  • Cell Cycle Proteins / immunology
  • Cell Cycle Proteins / metabolism
  • Cell Proliferation / drug effects
  • Diffusion of Innovation
  • Humans
  • Immunotherapy
  • Molecular Targeted Therapy
  • Signal Transduction / drug effects
  • Translational Research, Biomedical* / trends
  • Treatment Outcome
  • Urologic Neoplasms / drug therapy*
  • Urologic Neoplasms / enzymology
  • Urologic Neoplasms / immunology
  • Urologic Neoplasms / mortality
  • Urologic Neoplasms / pathology
  • Urothelium / drug effects*
  • Urothelium / enzymology
  • Urothelium / immunology
  • Urothelium / pathology

Substances

  • Antineoplastic Agents
  • Cell Cycle Proteins